169 related articles for article (PubMed ID: 28721365)
21. KMT2D links TGF-β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticity.
Lu S; Kim HS; Cao Y; Bedi K; Zhao L; Narayanan IV; Magnuson B; Gu Y; Yang J; Yi Z; Babaniamansour S; Shameon S; Xu C; Paulsen MT; Qiu P; Jeyarajan S; Ljungman M; Thomas D; Dou Y; Crawford H; di Magliano MP; Ge K; Yang B; Shi J
Int J Cancer; 2023 Aug; 153(3):552-570. PubMed ID: 37140208
[TBL] [Abstract][Full Text] [Related]
22. BMP-3 promotes mesenchymal stem cell proliferation through the TGF-beta/activin signaling pathway.
Stewart A; Guan H; Yang K
J Cell Physiol; 2010 Jun; 223(3):658-66. PubMed ID: 20143330
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
25. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway.
You L; Kruse FE
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):72-81. PubMed ID: 11773015
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
27. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
28. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
29. Activin A induces SLC5A8 expression through the Smad3 signaling pathway in human colon cancer RKO cells.
Zhang Y; Bao YL; Yang MT; Wu Y; Yu CL; Huang YX; Sun Y; Zheng LH; Li YX
Int J Biochem Cell Biol; 2010 Dec; 42(12):1964-72. PubMed ID: 20732443
[TBL] [Abstract][Full Text] [Related]
30. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
[TBL] [Abstract][Full Text] [Related]
31. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
32. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta.
Sokol JP; Neil JR; Schiemann BJ; Schiemann WP
Breast Cancer Res; 2005; 7(5):R844-53. PubMed ID: 16168131
[TBL] [Abstract][Full Text] [Related]
33. Activin-A, transforming growth factor-beta, and myostatin signaling pathway in experimental dilated cardiomyopathy.
Mahmoudabady M; Mathieu M; Dewachter L; Hadad I; Ray L; Jespers P; Brimioulle S; Naeije R; McEntee K
J Card Fail; 2008 Oct; 14(8):703-9. PubMed ID: 18926443
[TBL] [Abstract][Full Text] [Related]
34. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
35. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
[TBL] [Abstract][Full Text] [Related]
36. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
37. Intertwining of Activin A and TGFβ Signaling: Dual Roles in Cancer Progression and Cancer Cell Invasion.
Loomans HA; Andl CD
Cancers (Basel); 2014 Dec; 7(1):70-91. PubMed ID: 25560921
[TBL] [Abstract][Full Text] [Related]
38. miR-15a/miR-16 cluster inhibits invasion of prostate cancer cells by suppressing TGF-β signaling pathway.
Jin W; Chen F; Wang K; Song Y; Fei X; Wu B
Biomed Pharmacother; 2018 Aug; 104():637-644. PubMed ID: 29803177
[TBL] [Abstract][Full Text] [Related]
39. Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis.
Kwak T; Drews-Elger K; Ergonul A; Miller PC; Braley A; Hwang GH; Zhao D; Besser A; Yamamoto Y; Yamamoto H; El-Ashry D; Slingerland JM; Lippman ME; Hudson BI
Oncogene; 2017 Mar; 36(11):1559-1572. PubMed ID: 27669433
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of FOXP2 promotes breast cancer migration and invasion through TGFβ/SMAD signaling pathway.
Chen MT; Sun HF; Li LD; Zhao Y; Yang LP; Gao SP; Jin W
Oncol Lett; 2018 Jun; 15(6):8582-8588. PubMed ID: 29805593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
